National Cancer Institute (NCI) - Cancer Immunotherapy Trials Network (CITN) Hubs
%20-%20Cancer%20Immunotherapy%20Trials%20Network%20(CITN).png)
The Cancer Immunotherapy Trials Network (CITN) at the National Cancer Institute focuses on conducting clinical trials to evaluate novel immunotherapeutic approaches, including cancer vaccines. The network collaborates with academic institutions and industry partners to design and implement clinical trials that assess the safety and efficacy of new vaccine strategies. The CITN plays a crucial role in accelerating the development of cancer vaccines and bringing them to patients.